Pfizer Inc. said it is testing a three-dose course of the COVID-19 vaccine in all age groups under 16, including two to four-year-olds. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.